Radiation Oncology Journal10.3857/roj.2021.010532022402127-140Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility studyBudhi Singh Yadav, Shipra Gupta, Divya Dahiya, Ankita Gupta, Arun Singh Oinam,,
10.21203/ Hypofractionated Radiotherapy With Simultaneous Integrated Boost With Volumetric Modulated Arc Technique in Patients With Breast Cancer: a Phase 2 Study.Budhi Singh Yadav, Shipra Gupta, Divya Dahiya, Ankita Gupta, Arun Oinam,
Radiotherapy and Oncology10.1016/s0167-8140(12)71347-62012103S398-S399EP-1014 HYPOFRACTIONATED ACCELERATED RADIOTHERAPY BY SIMULTANEOUS INTEGRATED BOOST FOR HIGH RISK BREAST CANCER PATIENTSN. Rodríguez Ibarria, A. Cabezón, L. García, A. Riveros, M. Lloret, I. Ramírez, L.A. Henríquez-Hernández, A. Valenciano, P.C. Lara,
Radiotherapy and Oncology10.1016/s0167-8140(04)82654-9200473S338786 poster A dosimetric feasibility study of Conformal Radiotherapy (CRT) vs. Hypofractionated CRT (HCRT) vs. Intensity Modulated Radiotherapy (IMRT) vs. Simultaneously Integrated Hypofractionated Boost IMRT (SIHB) in prostate adenocarcinoma,
Breast Care10.1159/0004369512015105320-324Emerging Role of Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Modern Radiotherapy of Breast CancerMirko Nitsche, Juergen Dunst, Ulrich M. Carl, Robert M. Hermann,
Radiotherapy and Oncology10.1016/s0167-8140(02)83200-5200264S264892 Poster Accelerated hypofractionated radiotherapy using a ‘simultaneous integrated boost’ in locally advanced non-small cell lung cancer (NSCLC): A promising method for improving tumour control without increased toxicity,
Radiotherapy and Oncology10.1016/s0167-8140(04)80682-0200472S55-S56182 A dosimetric feasibility study of conformal radiotherapy (CRT) vs. intensity modulated radiotherapy (IMRT) vs. simultaneously integrated hypofractionated boost IMRT (SIHB) in prostate adenocarcinoma,
Radiotherapy and Oncology10.1016/s0167-8140(21)07012-22021161S564PD-0733 Tolerance of adjuvant moderate hypofractionated whole breast RT with simultaneous integrated boostL. Hoeng, O. Unterkirhere, A. Kaever, S. Abbeel, C. Glanzmann, G. Studer,
Radiotherapy and Oncology10.1016/j.radonc.2021.10.0242022166100Comment to “Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost”Yung-Shuo Kao,
Radiotherapy and Oncology10.1016/s0167-8140(12)71337-32012103S395EP-1004 PHASE I-II STUDY OF HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST (SIB) IN BREAST CANCER PATIENTSS. Pentimalli, F. Alongi, P. Navarria, F. Lobefalo, A.M. Ascolese, P. Mancosu, A. Fogliata, L. Cozzi, S. Arcangeli, M. Scorsetti,